Pay in 4 interest-free payments of $5.93 Learn more
Ships within 48 hours · Estimated delivery Aug 23 - Aug 28
Glenn Lyle conducts thorough consultations to evaluate your anatomy, health history, and goals
Your healthcare provider may recommend staying on a dose for longer than 4 weeks if you are experiencing side effects or if your current dose is effectively managing your blood sugar or weight
LY3437943 (Retatrutide): discovery to clinical proof of concept (triple GLP-1/GIP/glucagon agonist, preclinical mechanism) Nature Reviews Endocrinology (2024) Multi-receptor agonists for metabolic disease (mechanism of GLP-1/GIP/glucagon co-activation) Diabetes Care (2024) Incretin-based therapies: GLP-1, GIP, and glucagon receptor pharmacology (metabolic pathways, energy expenditure) NEJM (2023) Supplementary Material Jastreboff et al
So the foundation of eating on a GLP-1 is prioritizing nutrient-dense foods over empty calories
If your weekly weight average has not decreased by at least 1%, your caloric intake has not measurably dropped, and your hunger scores are unchanged, the microdose is likely sub-therapeutic for you
Understanding peptide receptor pharmacology clarifies why in-vitro results are just the first step
